MELAS syndrome with m.3243A>G heteroplasmic variant in a 12‑year‑old girl complicated by mitochondrial‑related diabetes: a case report
This case report describes a 12-year-old girl with MELAS syndrome caused by the m.3243A>G variant who presented with seizures, stroke-like lesions, and acute mitochondrial diabetes, highlighting the importance of early multidisciplinary diagnosis and management for favorable clinical outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside every cell of the human body, tiny power plants work tirelessly to convert food into the energy required for life. These structures, known as mitochondria, are unique because they carry their own distinct set of instructions, separate from the main genetic blueprint found in the cell's nucleus. When these instructions contain errors, the power plants fail to function correctly, leading to a group of conditions called mitochondrial diseases. Because energy is needed for almost every bodily function, these disorders can affect the brain, muscles, heart, and pancreas in unpredictable ways. One of the most common forms of this condition is a syndrome called MELAS, which stands for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. It is a complex puzzle where the body's energy systems falter, causing symptoms that often mimic more common illnesses like epilepsy or standard strokes, making it difficult for doctors to find the true cause quickly.
In a recent case report, researchers from the Second Hospital of Lanzhou University in China shared the story of a twelve-year-old girl who helped illuminate the complex nature of this disease. The girl had been healthy until she began experiencing intermittent seizures and, shortly after, a sudden fever accompanied by a severe headache. When doctors scanned her brain, they found something unusual: areas of swelling and damage that looked like strokes, but they did not follow the normal patterns of blood vessels. Instead, these lesions appeared in different parts of the brain over time, moving from the right side of the brain to the thalamus, a deep central structure. While the brain scans were alarming, the most surprising development occurred during her hospital stay. The child, who had no prior history of diabetes, suddenly developed dangerously high blood sugar levels and metabolic acidosis, a condition where the blood becomes too acidic. This combination of neurological collapse and sudden diabetes was a rare and critical clue.
The medical team faced a challenge because the symptoms could easily be mistaken for a severe infection, a standard stroke, or an autoimmune attack on the brain. To solve this, they looked beyond the immediate symptoms and examined the family history. They learned that the girl's mother had required insulin therapy for diabetes after giving birth, a pattern that hinted at a genetic link passed down from mother to child. By analyzing the girl's DNA, the doctors found a specific error in the mitochondrial instructions, a change in a single letter of the genetic code known as the m.3243A>G variant. This specific error was present in about two-thirds of her mitochondrial DNA, confirming that the girl had MELAS syndrome. The genetic test explained everything: the seizures, the migrating brain lesions, and the sudden failure of her pancreas to regulate sugar were all symptoms of the same underlying energy crisis.
Once the diagnosis was confirmed, the treatment plan shifted to support the failing power plants rather than just treating the symptoms. The doctors administered a specific cocktail of vitamins and supplements designed to help mitochondria produce energy more efficiently, while carefully avoiding certain medications that could make the mitochondrial damage worse. For the seizures, they used a safe medication that did not interfere with cellular energy. When the girl's blood sugar spiked, they used insulin to stabilize her metabolism, a necessary step to prevent a life-threatening crisis. Over the course of her hospitalization, the girl's condition improved dramatically. Her fever and headaches vanished, the seizures stopped, and the swelling in her brain began to shrink. By the time she was discharged, the strange lesions on her brain scans had almost completely disappeared, and her blood sugar levels remained stable without the need for aggressive intervention.
This case serves as a vital reminder for medical professionals and families alike. It shows that when a child presents with unexplained seizures, strange brain lesions that do not look like typical strokes, and new-onset diabetes, doctors should consider mitochondrial disease as a possible cause. The story of this twelve-year-old girl highlights the importance of looking at the whole picture, including family history, rather than treating each symptom in isolation. While there is no cure for MELAS yet, identifying the condition early allows for a tailored approach that can prevent severe complications and improve the quality of life for young patients. The successful management of her acute crisis and the resolution of her brain lesions demonstrate that with the right diagnosis and a multidisciplinary team, even severe mitochondrial disorders can be managed effectively.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.